{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:50:06Z","timestamp":1787629806399,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The surface of endothelial cells is covered with cell adhesion molecules including E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule 1 (VCAM-1) that mediate the adhesion and extravasation of leukocytes and play a pivotal role in inflammatory response. The aim of this study was to investigate the role of expression of adhesion molecules in inflammatory bowel disease (IBD) patients, irritable bowel syndrome (IBS) patients, and normal colonic mucosa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>IBS and IBD patients along with normal colonic mucosa were recruited in the study. In all groups, two biopsies were taken from each of the three anatomical sites (terminal ileum, cecum, and rectum). Three monoclonal antibodies, E-selectin mAb, VCAM-1 mAb, and ICAM-1 mAb, were applied for immunohistochemical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In IBD patients, the expression of intensity of E-selectin, VCAM-1, and ICAM-1 was found decreased, at least in cecum and rectum, in comparison with IBS patients and controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.005, and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.007, respectively). Comparison of the expression of intensity of the aforementioned molecules in IBS patients and controls revealed significant augmentation at the cecum and rectum of IBS patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The expression of adhesion molecules appeared lower in IBD patients compared to IBS patients and controls. In addition, the expression of adhesion molecules appeared higher in IBS compared to the control group. Therefore, it could be hypothesized that the expression of adhesion molecules could be considered as an early event in the process of proinflammatory IBS group and may be other factors play a crucial role in the process of intestinal inflammation in IBD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_2_20","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T06:32:05Z","timestamp":1630305125000},"page":"21","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Immunohistochemical Study of Adhesion Molecules in Irritable Bowel Syndrome"],"prefix":"10.4103","volume":"10","author":[{"given":"Antigony","family":"Mitselou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Grammeniatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Varouktsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatis S.","family":"Papadatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Klaroudas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Katsanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Galani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20240830","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/jlb.59.6.789","article-title":"Regulation of leukocyte adhesion and signaling in inflammation and disease","volume":"59","author":"Wahl","year":"1996","journal-title":"J Leukoc Biol"},{"key":"R2-21-20240830","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ibd.20501","article-title":"Leukocyte adhesion molecules in animal models of inflammatory bowel disease","volume":"14","author":"Rivera-Nieves","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R3-21-20240830","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-2001-11514","article-title":"Influence of natural and synthetic compounds on cell surface expression of cell adhesion molecules, ICAM-1 and VCAM-1","volume":"67","author":"Tanaka","year":"2001","journal-title":"Planta Med"},{"key":"R4-21-20240830","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00365529709025072","article-title":"Role of cell adhesion molecules in inflammatory bowel diseases","volume":"32","author":"Vainer","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"R5-21-20240830","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00042737-200202000-00007","article-title":"Differential expression of cell adhesion molecules within inflamed ileal pouch mucosa: Relationship to recruited cell subtypes","volume":"14","author":"Thomas","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R6-21-20240830","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.3748\/wjg.v16.i21.2616","article-title":"Mucosal biomarkers in inflammatory bowel disease: Key pathogenic players or disease predictors?","volume":"16","author":"Scaldaferri","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R7-21-20240830","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/ajg.2011.27","article-title":"Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment","volume":"106","author":"Arijs","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R8-21-20240830","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrgastro.2010.4","article-title":"Pathogenesis of IBS: Role of inflammation, immunity and neuroimmune interactions","volume":"7","author":"Ohman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R9-21-20240830","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4291\/wjgp.v1.i3.97","article-title":"Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome","volume":"1","author":"Akiho","year":"2010","journal-title":"World J Gastrointest Pathophysiol"},{"key":"R10-21-20240830","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.3748\/wjg.v22.i7.2242","article-title":"Inflammation in irritable bowel syndrome: Myth or new treatment target?","volume":"22","author":"Sinagra","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R11-21-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm6110099","article-title":"Rome criteria and a diagnostic approach to irritable bowel syndrome","volume":"6","author":"Lacy","year":"2017","journal-title":"J Clin Med"},{"key":"R12-21-20240830","first-page":"269","article-title":"Adhesion molecules in inflammatory bowel disease","volume":"7","author":"Kazimierczak","year":"2000","journal-title":"Gastroenterol Pol"},{"key":"R13-21-20240830","first-page":"56","article-title":"Important role of P-selectin for leucocyte recruitment, hepatocellular injury and apoptosis in endotoxemic mice","volume":"11","author":"Kintman","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"R14-21-20240830","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1096\/fasebj.9.10.7542214","article-title":"Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers","volume":"9","author":"Collins","year":"1995","journal-title":"FASEB J"},{"key":"R15-21-20240830","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1699-0463.1999.tb01477.x","article-title":"In situ expression of E-selectin and intercellular adhesion molecule-1 in chronic inflammatory diseases of the gastrointestinal tract","volume":"107","author":"Lazaris","year":"1999","journal-title":"APMIS"},{"key":"R16-21-20240830","first-page":"1197","article-title":"In-situ endothelial cell adhesion molecule expression in ulcerative colitis. E-selectin in-situ expression correlates with clinical, endoscopic and histological activity and outcome","volume":"9","author":"Cellier","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R17-21-20240830","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/apt.12369","article-title":"Meta-analysis using individual patient data: Efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis","volume":"38","author":"Vegter","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R18-21-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2353\/ajpath.2008.070502","article-title":"Mechanisms and consequences of neutrophil interaction with the endothelium","volume":"172","author":"Zarbock","year":"2008","journal-title":"Am J Pathol"},{"key":"R19-21-20240830","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00384-006-0236-0","article-title":"Adhesion molecules in chronic ulcerative colitis","volume":"22","author":"Gulubova","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"R20-21-20240830","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0016-5085(92)90015-Q","article-title":"Expression of vascular adhesion molecules in inflammatory bowel disease","volume":"103","author":"Koizumi","year":"1992","journal-title":"Gastroenterology"},{"key":"R21-21-20240830","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1365-2249.2000.01296.x","article-title":"Changed colonic profile of P-selectine, platelet-endothelial cell adhesion molecule-1 (PCAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel diseases","volume":"121","author":"Vainer","year":"2000","journal-title":"Clin Exp Imunol"},{"key":"R23-21-20240830","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1365-2036.2006.02837.x","article-title":"Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: A randomized, double-blind, active-controlled trial","volume":"23","author":"Miner","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R24-21-20240830","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1365-2036.2006.02910.x","article-title":"A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis","volume":"23","author":"van Deventer","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R25-21-20240830","doi-asserted-by":"crossref","first-page":"486067","DOI":"10.1155\/2012\/486067","article-title":"Phychopharmacological treatment and psychological intervention in irritable bowel syndrome","volume":"2012","author":"Sinagra","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"R26-21-20240830","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.3748\/wjg.v20.i10.2456","article-title":"Irritable bowel syndrome: Emerging paradigm in pathophysiology","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R27-21-20240830","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/eci.12548","article-title":"Immune dysregulation in the functional gastrointestinal disorders","volume":"45","author":"Keely","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"R28-21-20240830","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2007.01.046","article-title":"Immune activation in patients with irritable bowel syndrome","volume":"132","author":"Liebregts","year":"2007","journal-title":"Gastroenterology"},{"key":"R29-21-20240830","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2147\/JIR.S174982","article-title":"The role of inflammation in irritable bowel syndrome (IBS)","volume":"11","author":"Ng","year":"2018","journal-title":"J Inflamm Res"},{"key":"R30-21-20240830","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1136\/gutjnl-2013-305994","article-title":"Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome","volume":"63","author":"Jalanka-Tuovinen","year":"2014","journal-title":"Gut"},{"key":"R31-21-20240830","first-page":"G769","article-title":"Intestinal inflammation: A complex interplay of immune and nonimmune cell interactions","volume":"273","author":"Fiocchi","year":"1997","journal-title":"Am J Physiol"},{"key":"R32-21-20240830","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.2741\/3395","article-title":"Endothelial signaling in paracellular and transcellular leukocyte transmigration","volume":"14","author":"Wittchen","year":"2009","journal-title":"Front Biosci (Landmark Ed"},{"key":"R33-21-20240830","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02063969","article-title":"Up-regulation of E-selectin and intercellular adhesion molecule-1 differs between Crohn's disease and ulcerative colitis","volume":"40","author":"Pooley","year":"1995","journal-title":"Dig Dis Sci"},{"key":"R34-21-20240830","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13062-020-00280-5","article-title":"Pathophysiology of Crohn's disease inflammation and recurrence","volume":"15","author":"Petagna","year":"2020","journal-title":"Biol Direct"},{"key":"R35-21-20240830","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/iid3.395","article-title":"miR-223 improves intestinal inflammation through inhibiting the IL-6\/STAT3 signaling pathway in dextran sodium sulfate-induced experimental colitis","volume":"9","author":"Zhang","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"R36-21-20240830","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jlb.66.6.876","article-title":"Regulation of intercellular adhesion molecule-1 (CD54) gene expression","volume":"66","author":"Roebuck","year":"1999","journal-title":"J Leukoc Biol"},{"key":"R37-21-20240830","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1378\/chest.121.1.273","article-title":"Additional proteins in BAL fluid of Metsovites environmentally exposed to asbestos: More evidence of \u201cprotection\u201d against neoplasia?","volume":"121","author":"Galani","year":"2002","journal-title":"Chest"},{"key":"R38-21-20240830","doi-asserted-by":"crossref","first-page":"112951","DOI":"10.1016\/j.jep.2020.112951","article-title":"Intestinal anti-inflammatory effects of fuzi-ganjiang herb pair against DSS-induced ulcerative colitis in mice","volume":"261","author":"Huang","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"R39-21-20240830","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5217\/ir.2019.00125","article-title":"Proinflammatory cytokines in irritable bowel syndrome: A comparison with inflammatory bowel disease","volume":"18","author":"Mitselou","year":"2020","journal-title":"Intest Res"},{"key":"R40-21-20240830","first-page":"2271","article-title":"Syndecan-1, epithelial-mesenchymal transition markers (E-cadherin\/\u03b2-catenin) and neoangiogenesis-related proteins (PCAM-1 and Endoglin) in colorectal cancer","volume":"36","author":"Mitselou","year":"2016","journal-title":"Anticancer Res"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_2_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:32:33Z","timestamp":1786735953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_2_20"}},"subtitle":["A Comparison to Inflammatory Bowel Diseases"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_2_20","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}